Analisis Tingkat Keterpaparan Kegiatan Prolanis Pasien DM Tipe 2 Pada Dua Puskesmas Kota Bekasi

  • Lia WARTI, Warti STIKes Medistra Indonesia

Abstract

Chronic Disease Management Program (Prolanis) is a government program in the health service system that is implemented in an integrated manner and involves participants, health facilities and BPJS Kesehatan. Prolanis' goal is to encourage chronic disease participants to achieve an optimal quality of life so as to prevent complications. The implementation of Prolanis activities at a Health Facility may be different from other Health Facilities. To determine the success of implementing Prolanis activities at Health Facilities can be done by analyzing the level of exposure of Prolanis activities to type 2 DM patients at both puskesmas in Bekasi city. This study aims to analyze the exposure level of Prolanis activities in type 2 DM patients at PKM A and PKM B. The research method was descriptive analytic observational and was carried out in PKM A and PKM B with a total of 80 patients as respondents consisting of 40 type 2 DM patients at PKM A and 40 type 2 DM patients at PKM B within 1 (one) month. Prolanis activity data for each health center were collected using a questionnaire that met the validity and reliability test requirements. Prolanis activities carried out at the two puskesmas included medical consultations, club activities (gymnastics), group education, SMS gateways, home visits and health status monitoring. The results showed that the exposure level of Prolanis activities in PKM A was higher than PKM B.

References

[1]. Haida, N., Putri, K., & Isfandiari, M. A. (n.d.).2013 HUBUNGAN EMPAT PILAR PENGENDALIAN DM TIPE 2 DENGAN RERATA KADAR GULA DARAH Average Blood Sugar and Diabetus Mellitus Type II Management Analysis.
[2]. Warti,Laksmitawati, et.al 2022. Pengaruh Penerapan PROLANIS Pada PAsien Diabetes Melitus Tipe 2 Di Puskesmas Kota Bekasi.
[3]. BPJS. Panduan Praktis Prolanis (Program Pengelolaan Penyakit Kronis). BPJS Kesehatan; 2015.
[4]. Kementerian Kesehatan Republik Indonesia. Pusat Kesehatan Masyarakat. 2014.
[5]. Wayan, I., Putra, A., & Berawi, K. N. (2015). Ardana dan Khairun Nisa Berawi | Empat Pilar Penatalaksanaan Pasien Diabetes Mellitus Tipe 2 Majority | Volume (Vol. 4).
[6]. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. America: Diabetes Care. 2011; hlm. 34.
[7]. Irawan, D. Prevalensi dan Faktor Risiko Kejadian Diabetes Mellitus Tipe 2 di Daerah Urban Indonesia (analisa data sekunder riskesdas 2007). Depok: Universitas Indonesia Press; 2010.
[8]. Departemen Kesehatan Republik Indonesia. Pharmceutical Care Diabetes Melitus. Jakarta; 2005.
[9]. Adam, John.M.F. Klasifikasi dan Kriteria Diagnosis Diabetes Melitus Yang Baru. Cermin Dunia Kedokteran. Jakarta; 2010.
[10]. Musfirah Ahmad, Nurwahyuni. Korelasi Antara Pelaksanaan Prolanis Dengan Pengendalian Kadar Gula Darah Penderita Diabetes Melitus Tipe 2 Di Puskesmas Antang Dan Pampang Kota Makassar; 2018.
[11]. Fauzia Y, Sari E, dan Artini B. Gambaran Faktor-Faktor Yang Mempengaruhi Kepatuhan Diet Penderita Diabetes Melitus di Wilayah Puskesmas Pakis Surabaya; 2016.
[12]. Notoatmodjo, Soekidjo. Pendidikan dan Perilaku Kesehatan Jakarta: PT. Rineka Cipta; 2003, 12-33 dan 56-72.
[13]. Abdullah , Sjattar, E., Kadir, A.R. Faktor Penyebab Penurunan Jumlah Kunjungan Peserta Program Pengelolaan Penyakit Kronis (Prolanis) di Puskesmas Minasa Upa Kota Makassar; 2017.
[14]. Ahmad, dkk. Prolanis Implementatiom Effective To Control Fasting Blood Sugar, HbA1c And Total Cholesterol Levels in Patients with Type 2 Diabetes; 2017.
[15]. Hermansyah, dkk. Evaluasi Kegiatan prolanis di Wilayah kerja Puskesmas Banyumas; 2016.
Published
2023-08-04